Characteristics | Prevalence (%) (95% CI) | ||||
---|---|---|---|---|---|
Anti-HCV | Anti-HBV | Anti-HAV | Anti-HIV | Anti-HSV-2 | |
Age in years | |||||
21-29 | 2.3 (0.8 - 6.6) | 1.2 (0.4 - 3.3)a | 8.2 (5.1 - 12.7)c | *b, d | 14.8 (10.5 - 20.3)c |
30-39 | 2.5 (1.2 - 4.9) | 2.7 (1.3 - 5.4) | 13.9 (9.9 - 19.2) | 1.0 (0.3 - 3.5) | 15.5 (10.7 - 21.8) |
40-49 | 2.7 (1.3 - 5.4) | 3.6 (2.1 - 6.2) | 49.4 (41.7 - 57.2) | 1.7 (0.6 - 4.7) | 29.1 (24.2 - 34.5) |
50-64 | 1.3 (0.4 - 4.4) | 5.4 (3.3 - 8.6) | 89.0 (84.6 - 92.2) | 0.7 (0.2 - 2.0) | 29.0 (23.3 - 35.4) |
Sex | |||||
Female | 1.0 (0.4 - 2.1)b | 2.5 (1.6 - 3.9) | 41.3 (36.7 - 46.0) | 0.8 (0.3 - 2.0) | 25.6 (21.5 - 30.2)b |
Male | 4.0 (2.3 - 6.8) | 4.3 (2.7 - 6.8) | 41.5 (36.7 - 46.5) | 1.0 (0.4 - 2.4) | 17.8 (14.3 - 22.1) |
Years of education | |||||
≥ 12 | 2.2 (1.3 - 3.6) | 2.5 (1.7 - 3.9)a | 35.8 (32.3 - 39.4)c | 0.6 (0.2 - 1.5) | 20.2 (17.2 - 23.5)b |
< 12 | 2.3 (1.0 - 5.3) | 5.7 (3.7 - 8.6) | 59.3 (54.5 - 63.9) | 1.7 (0.7 - 4.3) | 29.3 (22.8 - 36.8) |
Annual family income | |||||
≥ $20,000 | 1.4 (0.4 - 4.4) | 1.1 (0.5 - 2.6)b | 32.9 (28.6 - 37.5)c | 1.1 (0.4 - 3.4) | 16.9 (12.8 - 21.9)b |
< $20,000 | 2.3 (1.3 - 4.0) | 4.0 (2.9 - 5.6) | 45.9 (41.8 - 50.1) | 0.6 (0.2 - 1.6) | 25.9 (21.8 - 30.5) |
Health care coverage | |||||
Private | 0.4 (0.2 - 0.9)c | 2.2 (1.3 - 3.7) | 43.8 (38.9 - 48.9) | 0.8 (0.2 - 2.3) | 17.3 (14.0 - 21.3)c |
Public | 4.1 (2.4 - 6.9) | 4.5 (3.0 - 6.7) | 40.6 (36.0 - 45.3) | 0.8 (0.3 - 1.9) | 27.6 (23.0 - 32.6) |
None | 2.9 (0.8 - 9.6) | 3.4 (1.4 - 8.2) | 33.9 (24.2 - 45.1) | 1.6 (0.3 - 7.8) | 24.0 (16.5 - 33.6) |
Age at first sexual intercourse | |||||
< 12 | 10.2 (3.3 - 27.2)c | 15.2 (5.7 - 34.5)b | 57.2 (38.8 - 73.8) | 2.0 (0.5 - 8.4) | 33.1 (18.7 - 51.6) |
12-17 | 3.6 (2.0 - 6.1) | 3.7 (2.4 - 5.7) | 38.3 (33.9 - 42.9) | 0.9 (0.4 - 2.3) | 23.9 (19.4 - 29.2) |
≥ 18 | 0.5 (0.2 - 1.1) | 1.9 (1.1 - 3.3) | 43.2 (38.9 - 47.6) | 0.3 (0.1 - 1.6) | 20.1 (16.4 - 24.4) |
Number of lifetime sexual partners | |||||
0-1 | 0.7 (0.1 - 3.3)c | 1.9 (0.9 - 4.0) | 50.9 (44.3 - 57.6)b | *d | 11.5 (7.9 - 16.5)c |
2-9 | 1.2 (0.6 - 2.6) | 2.7 (1.8 - 4.2) | 37.4 (33.5 - 41.4) | 0.9 (0.4 - 2.3) | 24.1 (20.1 - 28.6) |
≥ 10 | 5.5 (3.0 - 9.8) | 4.6 (2.6 - 8.0) | 41.5 (33.2 - 50.3) | 0.7 (0.2 - 1.9) | 25.1 (19.9 - 31.1) |
Men who have sex with men | |||||
Never | 4.0 (2.3 - 6.9) | 4.3 (2.6 - 7.1) | 41.2 (36.3 - 46.2) | 0.3 (0.1 - 0.9)c | 16.8 (12.9 - 21.5) |
Ever | 2.6 (0.7 - 9.3) | 3.1 (0.7 - 13.0) | 49.9 (31.9 - 67.9) | 7.3 (1.9 - 24.5) | 22.0 (11.5 - 38.1) |
Lifetime drug use | |||||
None | 0.6 (0.2 - 1.6)c | 2.6 (1.7 - 3.9)c | 47.7 (44.1 - 51.4)c | 0.7 (0.3 - 1.9) | 20.3 (16.6 - 24.5) |
Non-IDU | 1.8 (0.9 - 3.5) | 3.5 (2.1 - 5.8) | 29.3 (24.3 - 34.9) | 1.0 (0.4 - 2.8) | 25.4 (20.9 - 30.6) |
IDU | 76.1 (55.2 - 89.1) | 23.5 (8.8 - 49.3) | 66.9 (42.9 - 84.5) | 2.8 (0.6 - 12.4) | 31.9 (10.3 - 65.5) |
Tattooing practice | |||||
Never | 0.9 (0.5 - 1.6)c | 2.9 (2.0 - 4.0) | 43.7 (40.4 - 47.0)c | 0.6 (0.3 - 1.4) | 21.8 (18.2 - 25.8) |
Ever | 10.2 (6.0 - 16.8) | 5.6 (2.8 - 11.1) | 27.5 (21.4 - 34.6) | 2.2 (0.6 - 7.1) | 26.2 (19.8 - 33.9) |
Body piercing | |||||
Never | 1.4 (0.8 - 2.6)a | 3.6 (2.5 - 5.1) | 48.9 (45.2 - 52.7)c | 1.0 (0.5 - 2.2) | 23.0 (20.0 - 26.4) |
Ever | 4.0 (2.1 - 7.5) | 2.7 (1.3 - 5.6) | 24.4 (19.9 - 29.6) | 0.5 (0.1 - 2.1) | 21.0 (15.8 - 27.5) |
Blood transfusions prior to 1992 | |||||
Never | 2.0 (1.2 - 3.2)b | 2.9 (2.1 - 4.0)b | 40.1 (37.1 - 43.3)c | 0.4 (0.2 - 1.0)c | 21.9 (18.6 - 25.6) |
Ever | 6.3 (2.5 - 14.6) | 11.6 (5.3 - 23.6) | 65.2 (52.7 - 75.8) | 9.2 (3.4 - 22.8) | 31.2 (19.6 - 45.7) |
History of other STIse | |||||
Yes | 2.7 (0.7 - 9.1) | 4.9 (2.2 - 10.7) | 47.3 (35.0 - 59.8) | 5.9 (1.9 - 16.5)b | 33.9 (22.7 - 47.3)a |
No | 2.2 (1.3 - 3.6) | 3.2 (2.3 - 4.5) | 41.1 (37.9 - 44.3) | 0.6 (0.3 - 1.4) | 21.9 (18.6 - 25.6) |
History of imprisonment | |||||
Never | 0.8 (0.4 - 1.5)c | 2.6 (1.8 - 3.7)b | 41.2 (37.8 - 44.7) | 0.6 (0.2 - 1.3)b | 21.1 (18.1 - 24.5)b |
Ever | 17.5 (11.4 - 26.1) | 11.2 (5.4 - 21.7) | 43.0 (33.5 - 53.0) | 4.1 (1.4 - 10.9) | 36.0 (25.4 - 48.0) |